Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [335]

Transarterial chemoembolization with or without sorafenib for intermediate...

Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an...

Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma ( Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an, China )

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse...

Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction ( Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA )

Promising results for nivolumab in advanced liver cancer

Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive...

Promising results for nivolumab in advanced liver cancer ( Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA )

Nivolumab shows highly promising activity in advanced liver cancer in early...

Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive...

Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial ( Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA )

Real-world targeted treatment based on whole genome sequencing difficult in...

Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst...

Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer ( Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst, Australia )

PARP inhibitor combo shows early promise for patients with and without BRCA...

Dr Timothy Yap - Royal Marsden Hospital, London, UK

PARP inhibitor combo shows early promise for patients with and without BRCA mutations ( Dr Timothy Yap - Royal Marsden Hospital, London, UK )

Incidences of liver cancer rising in the USA

Dr Anna Mae Diehl - Duke University Medical Center, Durham, USA

Incidences of liver cancer rising in the USA ( Dr Anna Mae Diehl - Duke University Medical Center, Durham, USA )

New approaches and new partnership models for biomarker based clinical research

Dr Denis Lacombe, EORTC, Brussels, Belgium

New approaches and new partnership models for biomarker based clinical research ( Dr Denis Lacombe, EORTC, Brussels, Belgium )

Aims and successes of the 2nd EurocanPlatform project translational research...

Christina von Gertten, Karolinska Institutet, Stockholm, Sweden

Aims and successes of the 2nd EurocanPlatform project translational research course ( Christina von Gertten, Karolinska Institutet, Stockholm, Sweden )

Epigenome deregulation in cancer

Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon...

Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )

Immunotherapy of cancer: recent progress and future challenges

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden

Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )

Reasons to attend the EurocanPlatform translational research course 2015

Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany

Reasons to attend the EurocanPlatform translational research course 2015 ( Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany )

More from ecancer